Annual CFF
$644.08 M
+$699.38 M+1264.81%
31 December 2023
Summary:
Ionis Pharmaceuticals annual cash flow from financing activities is currently $644.08 million, with the most recent change of +$699.38 million (+1264.81%) on 31 December 2023. During the last 3 years, it has risen by +$1.24 billion (+207.96%). IONS annual CFF is now at all-time high.IONS Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$496.05 M
+$493.49 M+19299.57%
30 September 2024
Summary:
Ionis Pharmaceuticals quarterly cash flow from financing activities is currently $496.05 million, with the most recent change of +$493.49 million (+19299.57%) on 30 September 2024. Over the past year, it has increased by +$528.31 million (+1637.32%). IONS quarterly CFF is now at all-time high.IONS Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$562.90 M
+$528.31 M+1527.63%
30 September 2024
Summary:
Ionis Pharmaceuticals TTM cash flow from financing activities is currently $562.90 million, with the most recent change of +$528.31 million (+1527.63%) on 30 September 2024. Over the past year, it has increased by +$10.56 million (+1.91%). IONS TTM CFF is now -12.60% below its all-time high of $644.08 million, reached on 31 December 2023.IONS TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IONS Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1264.8% | +1637.3% | +1.9% |
| 3 y3 years | +208.0% | +10000.0% | +364.2% |
| 5 y5 years | +35.4% | +3865.3% | +522.4% |
IONS Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +208.0% | at high | +893.8% | -12.6% | +364.2% |
| 5 y | 5 years | at high | +208.0% | at high | +195.1% | -12.6% | +194.3% |
| alltime | all time | at high | +208.0% | at high | +195.1% | -12.6% | +194.3% |
Ionis Pharmaceuticals Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $496.05 M(>+9900.0%) | $562.90 M(+1527.6%) |
| June 2024 | - | $2.56 M(-89.2%) | $34.58 M(-80.3%) |
| Mar 2024 | - | $23.57 M(-42.1%) | $175.56 M(-72.7%) |
| Dec 2023 | $644.08 M(-1264.8%) | $40.72 M(-226.2%) | $644.08 M(+16.6%) |
| Sept 2023 | - | -$32.27 M(-122.5%) | $552.34 M(-5.8%) |
| June 2023 | - | $143.54 M(-70.8%) | $586.44 M(+32.0%) |
| Mar 2023 | - | $492.09 M(-1064.5%) | $444.12 M(-903.2%) |
| Dec 2022 | -$55.30 M(-122.5%) | -$51.02 M(-2881.8%) | -$55.30 M(-17.2%) |
| Sept 2022 | - | $1.83 M(+50.9%) | -$66.77 M(-0.6%) |
| June 2022 | - | $1.22 M(-116.6%) | -$67.14 M(-127.3%) |
| Mar 2022 | - | -$7.33 M(-88.3%) | $246.19 M(+0.1%) |
| Dec 2021 | $245.93 M(-141.2%) | -$62.49 M(-4386.0%) | $245.93 M(-215.4%) |
| Sept 2021 | - | $1.46 M(-99.5%) | -$213.06 M(+4.7%) |
| June 2021 | - | $314.54 M(-4251.3%) | -$203.58 M(-60.1%) |
| Mar 2021 | - | -$7.58 M(-98.5%) | -$509.69 M(-14.6%) |
| Dec 2020 | -$596.61 M(-696.5%) | -$521.48 M(-4868.0%) | -$596.61 M(+967.2%) |
| Sept 2020 | - | $10.94 M(+29.7%) | -$55.90 M(-30.1%) |
| June 2020 | - | $8.44 M(-108.9%) | -$80.02 M(+48.3%) |
| Mar 2020 | - | -$94.50 M(-591.6%) | -$53.94 M(-153.9%) |
| Dec 2019 | $100.02 M(-79.0%) | $19.23 M(-245.9%) | $100.02 M(+10.6%) |
| Sept 2019 | - | -$13.17 M(-138.2%) | $90.44 M(-19.0%) |
| June 2019 | - | $34.51 M(-42.0%) | $111.69 M(-78.9%) |
| Mar 2019 | - | $59.46 M(+516.4%) | $530.10 M(+11.4%) |
| Dec 2018 | $475.87 M(+107.7%) | $9.65 M(+19.4%) | $475.87 M(+1.1%) |
| Sept 2018 | - | $8.08 M(-98.2%) | $470.48 M(-22.9%) |
| June 2018 | - | $452.92 M(+8570.0%) | $609.97 M(+284.2%) |
| Mar 2018 | - | $5.22 M(+22.7%) | $158.76 M(-30.7%) |
| Dec 2017 | $229.09 M(+1910.6%) | $4.26 M(-97.1%) | $229.09 M(-0.9%) |
| Sept 2017 | - | $147.57 M(+8519.9%) | $231.28 M(+162.1%) |
| June 2017 | - | $1.71 M(-97.7%) | $88.25 M(+2.5%) |
| Mar 2017 | - | $75.55 M(+1071.6%) | $86.06 M(+655.3%) |
| Dec 2016 | $11.39 M(-53.9%) | $6.45 M(+41.9%) | $11.39 M(-31.6%) |
| Sept 2016 | - | $4.54 M(-1054.4%) | $16.66 M(+35.6%) |
| June 2016 | - | -$476.00 K(-154.2%) | $12.28 M(-12.7%) |
| Mar 2016 | - | $879.00 K(-92.5%) | $14.08 M(-43.1%) |
| Dec 2015 | $24.73 M(-58.5%) | $11.71 M(+6914.4%) | $24.73 M(-60.7%) |
| Sept 2015 | - | $167.00 K(-87.3%) | $62.89 M(-2.4%) |
| June 2015 | - | $1.32 M(-88.6%) | $64.41 M(+4.2%) |
| Mar 2015 | - | $11.53 M(-76.9%) | $61.80 M(+3.7%) |
| Dec 2014 | $59.59 M(-73.8%) | $49.88 M(+2865.6%) | $59.59 M(+357.2%) |
| Sept 2014 | - | $1.68 M(-230.6%) | $13.03 M(-54.6%) |
| June 2014 | - | -$1.29 M(-113.8%) | $28.71 M(-87.4%) |
| Mar 2014 | - | $9.31 M(+179.9%) | $227.99 M(+0.1%) |
| Dec 2013 | $227.72 M(+482.0%) | $3.33 M(-80.8%) | $227.72 M(+2.0%) |
| Sept 2013 | - | $17.36 M(-91.2%) | $223.25 M(-7.1%) |
| June 2013 | - | $197.99 M(+2087.8%) | $240.29 M(+380.3%) |
| Mar 2013 | - | $9.05 M(-886.3%) | $50.03 M(+27.9%) |
| Dec 2012 | $39.13 M(-5922.9%) | -$1.15 M(-103.3%) | $39.13 M(-4.2%) |
| Sept 2012 | - | $34.40 M(+344.6%) | $40.87 M(+632.2%) |
| June 2012 | - | $7.74 M(-517.5%) | $5.58 M(-410.6%) |
| Mar 2012 | - | -$1.85 M(-416.8%) | -$1.80 M(+167.4%) |
| Dec 2011 | -$672.00 K(-114.3%) | $585.00 K(-165.9%) | -$672.00 K(-147.4%) |
| Sept 2011 | - | -$888.00 K(-347.4%) | $1.42 M(-25.6%) |
| June 2011 | - | $359.00 K(-149.3%) | $1.91 M(-51.2%) |
| Mar 2011 | - | -$728.00 K(-127.2%) | $3.90 M(-17.0%) |
| Dec 2010 | $4.70 M(-97.7%) | $2.67 M(-767.1%) | $4.70 M(+3.0%) |
| Sept 2010 | - | -$401.00 K(-117.0%) | $4.56 M(-55.1%) |
| June 2010 | - | $2.35 M(+3361.8%) | $10.15 M(+16.8%) |
| Mar 2010 | - | $68.00 K(-97.3%) | $8.69 M(-95.7%) |
| Dec 2009 | $202.00 M(+87.8%) | $2.54 M(-51.1%) | $202.00 M(-3.2%) |
| Sept 2009 | - | $5.19 M(+482.4%) | $208.78 M(+1.5%) |
| June 2009 | - | $891.00 K(-99.5%) | $205.74 M(-10.6%) |
| Mar 2009 | - | $193.38 M(+1975.4%) | $230.02 M(+113.8%) |
| Dec 2008 | $107.58 M(+146.5%) | $9.32 M(+333.4%) | $107.58 M(+6.5%) |
| Sept 2008 | - | $2.15 M(-91.5%) | $101.02 M(-9.5%) |
| June 2008 | - | $25.17 M(-64.5%) | $111.67 M(+3349.8%) |
| Mar 2008 | - | $70.95 M(+2480.0%) | $3.24 M(-92.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2007 | $43.65 M(-70.8%) | $2.75 M(-78.5%) | $43.65 M(-62.4%) |
| Sept 2007 | - | $12.80 M(-115.4%) | $116.19 M(+8.5%) |
| June 2007 | - | -$83.27 M(-174.8%) | $107.05 M(-58.8%) |
| Mar 2007 | - | $111.36 M(+47.9%) | $260.04 M(+74.0%) |
| Dec 2006 | $149.46 M(+297.5%) | $75.29 M(+1957.6%) | $149.46 M(+108.3%) |
| Sept 2006 | - | $3.66 M(-94.8%) | $71.76 M(-34.7%) |
| June 2006 | - | $69.73 M(+8771.4%) | $109.88 M(+205.3%) |
| Mar 2006 | - | $786.00 K(-132.6%) | $35.99 M(-4.3%) |
| Dec 2005 | $37.60 M(+209.4%) | -$2.41 M(-105.8%) | $37.60 M(-18.2%) |
| Sept 2005 | - | $41.77 M(-1105.6%) | $45.95 M(+596.0%) |
| June 2005 | - | -$4.15 M(-273.5%) | $6.60 M(-51.1%) |
| Mar 2005 | - | $2.39 M(-59.7%) | $13.50 M(+11.1%) |
| Dec 2004 | $12.15 M(-71.0%) | $5.94 M(+145.5%) | $12.15 M(-45.4%) |
| Sept 2004 | - | $2.42 M(-11.8%) | $22.24 M(-13.9%) |
| June 2004 | - | $2.74 M(+161.7%) | $25.84 M(-25.3%) |
| Mar 2004 | - | $1.05 M(-93.5%) | $34.59 M(-17.4%) |
| Dec 2003 | $41.85 M(-67.7%) | $16.03 M(+166.3%) | $41.85 M(-23.0%) |
| Sept 2003 | - | $6.02 M(-47.6%) | $54.34 M(+19.6%) |
| June 2003 | - | $11.49 M(+38.2%) | $45.44 M(-64.9%) |
| Mar 2003 | - | $8.31 M(-70.8%) | $129.43 M(-0.1%) |
| Dec 2002 | $129.59 M(-45.3%) | $28.51 M(-1090.0%) | $129.59 M(-43.5%) |
| Sept 2002 | - | -$2.88 M(-103.0%) | $229.21 M(-27.0%) |
| June 2002 | - | $95.49 M(+1027.0%) | $314.17 M(+28.0%) |
| Mar 2002 | - | $8.47 M(-93.4%) | $245.40 M(+3.5%) |
| Dec 2001 | $237.04 M(+92.9%) | $128.13 M(+56.1%) | $237.04 M(+87.1%) |
| Sept 2001 | - | $82.08 M(+207.2%) | $126.70 M(+180.4%) |
| June 2001 | - | $26.72 M(>+9900.0%) | $45.18 M(-19.4%) |
| Mar 2001 | - | $116.00 K(-99.3%) | $56.07 M(-54.4%) |
| Dec 2000 | $122.88 M(+92.3%) | $17.79 M(+3110.8%) | $122.88 M(-6.8%) |
| Sept 2000 | - | $554.00 K(-98.5%) | $131.80 M(-7.0%) |
| June 2000 | - | $37.62 M(-43.8%) | $141.64 M(+8.7%) |
| Mar 2000 | - | $66.93 M(+150.7%) | $130.33 M(+104.0%) |
| Dec 1999 | $63.90 M(+323.2%) | $26.70 M(+156.7%) | $63.90 M(+70.4%) |
| Sept 1999 | - | $10.40 M(-60.5%) | $37.50 M(+41.5%) |
| June 1999 | - | $26.30 M(+5160.0%) | $26.50 M(+85.3%) |
| Mar 1999 | - | $500.00 K(+66.7%) | $14.30 M(-5.3%) |
| Dec 1998 | $15.10 M(-58.9%) | $300.00 K(-150.0%) | $15.10 M(-62.6%) |
| Sept 1998 | - | -$600.00 K(-104.3%) | $40.40 M(-4.0%) |
| June 1998 | - | $14.10 M(+984.6%) | $42.10 M(+12.0%) |
| Mar 1998 | - | $1.30 M(-94.9%) | $37.60 M(+2.5%) |
| Dec 1997 | $36.70 M(+59.6%) | $25.60 M(+2227.3%) | $36.70 M(+10.2%) |
| Sept 1997 | - | $1.10 M(-88.5%) | $33.30 M(+4.7%) |
| June 1997 | - | $9.60 M(+2300.0%) | $31.80 M(+37.1%) |
| Mar 1997 | - | $400.00 K(-98.2%) | $23.20 M(+0.9%) |
| Dec 1996 | $23.00 M(-54.1%) | $22.20 M(-5650.0%) | $23.00 M(-16.1%) |
| Sept 1996 | - | -$400.00 K(-140.0%) | $27.40 M(-44.0%) |
| June 1996 | - | $1.00 M(+400.0%) | $48.90 M(-3.6%) |
| Mar 1996 | - | $200.00 K(-99.2%) | $50.70 M(+1.2%) |
| Dec 1995 | $50.10 M(+1254.1%) | $26.60 M(+26.1%) | $50.10 M(+115.9%) |
| Sept 1995 | - | $21.10 M(+653.6%) | $23.20 M(+866.7%) |
| June 1995 | - | $2.80 M(-800.0%) | $2.40 M(-260.0%) |
| Mar 1995 | - | -$400.00 K(+33.3%) | -$1.50 M(-140.5%) |
| Dec 1994 | $3.70 M(-90.7%) | -$300.00 K(-200.0%) | $3.70 M(-85.7%) |
| Sept 1994 | - | $300.00 K(-127.3%) | $25.80 M(-3.0%) |
| June 1994 | - | -$1.10 M(-122.9%) | $26.60 M(-1.8%) |
| Mar 1994 | - | $4.80 M(-78.0%) | $27.10 M(-32.1%) |
| Dec 1993 | $39.90 M(-2760.0%) | $21.80 M(+1881.8%) | $39.90 M(+138.9%) |
| Sept 1993 | - | $1.10 M(-283.3%) | $16.70 M(+10.6%) |
| June 1993 | - | -$600.00 K(-103.4%) | $15.10 M(-7.9%) |
| Mar 1993 | - | $17.60 M(-1357.1%) | $16.40 M(-1193.3%) |
| Dec 1992 | -$1.50 M(-102.3%) | -$1.40 M(+180.0%) | -$1.50 M(-105.0%) |
| Sept 1992 | - | -$500.00 K(-171.4%) | $30.30 M(-1.0%) |
| June 1992 | - | $700.00 K(-333.3%) | $30.60 M(-41.6%) |
| Mar 1992 | - | -$300.00 K(-101.0%) | $52.40 M(-18.8%) |
| Dec 1991 | $64.50 M | $30.40 M(<-9900.0%) | $64.50 M(+89.1%) |
| Sept 1991 | - | -$200.00 K(-100.9%) | $34.10 M(-0.6%) |
| June 1991 | - | $22.50 M(+90.7%) | $34.30 M(+190.7%) |
| Mar 1991 | - | $11.80 M | $11.80 M |
FAQ
- What is Ionis Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals annual CFF year-on-year change?
- What is Ionis Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals quarterly CFF year-on-year change?
- What is Ionis Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals TTM CFF year-on-year change?
What is Ionis Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of IONS is $644.08 M
What is the all time high annual CFF for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high annual cash flow from financing activities is $644.08 M
What is Ionis Pharmaceuticals annual CFF year-on-year change?
Over the past year, IONS annual cash flow from financing activities has changed by +$699.38 M (+1264.81%)
What is Ionis Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of IONS is $496.05 M
What is the all time high quarterly CFF for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high quarterly cash flow from financing activities is $496.05 M
What is Ionis Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, IONS quarterly cash flow from financing activities has changed by +$528.31 M (+1637.32%)
What is Ionis Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of IONS is $562.90 M
What is the all time high TTM CFF for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high TTM cash flow from financing activities is $644.08 M
What is Ionis Pharmaceuticals TTM CFF year-on-year change?
Over the past year, IONS TTM cash flow from financing activities has changed by +$10.56 M (+1.91%)